Cargando…

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey

BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from...

Descripción completa

Detalles Bibliográficos
Autores principales: Fromer, Leonard M, Ortiz, Gabriel R, Dowdee, April M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651039/
https://www.ncbi.nlm.nih.gov/pubmed/23282579
http://dx.doi.org/10.1097/WOX.0b013e3181865f99
_version_ 1782269152453459968
author Fromer, Leonard M
Ortiz, Gabriel R
Dowdee, April M
author_facet Fromer, Leonard M
Ortiz, Gabriel R
Dowdee, April M
author_sort Fromer, Leonard M
collection PubMed
description BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from its therapeutic effects. OBJECTIVE: To determine whether the characteristics of the mometasone furoate nasal spray (MFNS) delivery device are an impediment to its use. METHODS/DATABASE: A random sample of preidentified MFNS users was recruited through e-mail (N = 1544). In online interviews, participants were asked about MFNS ease of use and attributes. RESULTS: Ninety-eight percent of respondents reported that MFNS is easy to use, and 96% said that the applicator is easy to administer. Nearly all elderly users and users with arthritis said that the applicator fits comfortably in the nostril (96% and 97%, respectively) and is appropriately sized (97% and 96%, respectively); 96% of pediatric users agreed that the applicator fits comfortably. All users said the applicator's ease of use and comfortable fit were its most important attributes. CONCLUSIONS: The perceived ease of use of MFNS may help providers appropriately treat patients with allergic rhinitis and may improve patient adherence to INS use.
format Online
Article
Text
id pubmed-3651039
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36510392013-07-12 Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey Fromer, Leonard M Ortiz, Gabriel R Dowdee, April M World Allergy Organ J Original Research BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from its therapeutic effects. OBJECTIVE: To determine whether the characteristics of the mometasone furoate nasal spray (MFNS) delivery device are an impediment to its use. METHODS/DATABASE: A random sample of preidentified MFNS users was recruited through e-mail (N = 1544). In online interviews, participants were asked about MFNS ease of use and attributes. RESULTS: Ninety-eight percent of respondents reported that MFNS is easy to use, and 96% said that the applicator is easy to administer. Nearly all elderly users and users with arthritis said that the applicator fits comfortably in the nostril (96% and 97%, respectively) and is appropriately sized (97% and 96%, respectively); 96% of pediatric users agreed that the applicator fits comfortably. All users said the applicator's ease of use and comfortable fit were its most important attributes. CONCLUSIONS: The perceived ease of use of MFNS may help providers appropriately treat patients with allergic rhinitis and may improve patient adherence to INS use. World Allergy Organization 2008-09-15 /pmc/articles/PMC3651039/ /pubmed/23282579 http://dx.doi.org/10.1097/WOX.0b013e3181865f99 Text en Copyright ©2008 World Allergy Organization; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Fromer, Leonard M
Ortiz, Gabriel R
Dowdee, April M
Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title_full Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title_fullStr Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title_full_unstemmed Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title_short Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
title_sort assessment of patient attitudes about mometasone furoate nasal spray: the ease-of-use patient survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651039/
https://www.ncbi.nlm.nih.gov/pubmed/23282579
http://dx.doi.org/10.1097/WOX.0b013e3181865f99
work_keys_str_mv AT fromerleonardm assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey
AT ortizgabrielr assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey
AT dowdeeaprilm assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey